Islet α-cell Inflammation Induced By NF-κB inducing kinase (NIK) Leads to Hypoglycemia, Pancreatitis, Growth Retardation, and Postnatal Death in Mice
暂无分享,去创建一个
L. Rui | Liwei Xie | G. Gittes | C. Shiota | Ying Chen | Ming Liu | Xinzhi Li | Ying Dong | Xiao-Fang Ren | Linna Jia | Zheng Chen | Yuefan Dong | Xiaoyue Chen | Ying Dong | Liangyou Rui
[1] S. Dry,et al. Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetes. , 2017, JCI insight.
[2] L. Rui,et al. A small‐molecule inhibitor of NF‐κB‐inducing kinase (NIK) protects liver from toxin‐induced inflammation, oxidative stress, and injury , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] Vinay Tergaonkar,et al. Noncanonical NF-κB Signaling in Health and Disease. , 2016, Trends in molecular medicine.
[4] A. Waisman,et al. NF‐κB‐inducing kinase is essential for B‐cell maintenance in mice , 2016, European journal of immunology.
[5] B. Becher,et al. The NFκB-inducing kinase is essential for the developmental programming of skin-resident and IL-17-producing γδ T cells , 2015, eLife.
[6] Liang Sheng,et al. Mouse hepatocyte overexpression of NF‐κB‐inducing kinase (NIK) triggers fatal macrophage‐dependent liver injury and fibrosis , 2014, Hepatology.
[7] L. Rui,et al. SH2B1 in β-cells promotes insulin expression and glucose metabolism in mice. , 2014, Molecular endocrinology.
[8] L. Rui,et al. SH2B1 in β-Cells Regulates Glucose Metabolism by Promoting β-Cell Survival and Islet Expansion , 2014, Diabetes.
[9] K. Prasadan,et al. α-Cells are dispensable in postnatal morphogenesis and maturation of mouse pancreatic islets. , 2013, American journal of physiology. Endocrinology and metabolism.
[10] A. Dobrian,et al. Islet inflammation: a unifying target for diabetes treatment? , 2013, Trends in Endocrinology & Metabolism.
[11] M. Karin,et al. Inflammation, autophagy, and obesity: common features in the pathogenesis of pancreatitis and pancreatic cancer. , 2013, Gastroenterology.
[12] Adam R. Johnson,et al. The crystal structure of the catalytic domain of the NF-κB inducing kinase reveals a narrow but flexible active site. , 2012, Structure.
[13] L. Rui,et al. NF-κB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action , 2012, Nature Medicine.
[14] Yoshitaka Hayashi. Metabolic impact of glucagon deficiency , 2011, Diabetes, obesity & metabolism.
[15] Aidan S. Hancock,et al. Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice. , 2010, Molecular endocrinology.
[16] S. Nishikawa,et al. NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells , 2008, Proceedings of the National Academy of Sciences.
[17] M. Prentki,et al. Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. , 2000, Diabetes.
[18] Shao-Cong Sun,et al. Non-canonical NF-κB signaling pathway , 2011, Cell Research.
[19] G. Xiao,et al. Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation. , 2004, The Journal of biological chemistry.